RNA-exporting machine deciphered

Mar 29, 2011 by Dan Krotz
The closest look yet at the molecular machinery that helps transport messenger RNA from a cell’s nucleus. In this image, Dbp5 (blue-grey) and Gle1 (yellow) are glued together by IP6 (colored spheres). (Image courtesy of Karsten Weis’ and James Berger’s labs)

(PhysOrg.com) -- A tiny motor tasked with one of nature’s biggest jobs is now better understood. The molecular machinery that helps export messenger RNA from a cell’s nucleus has been structurally mapped at the Advanced Light Source, a synchrotron located at the U.S. Department of Energy’s Lawrence Berkeley National Laboratory (Berkeley Lab).

Messenger RNA conveys genetic information from the nucleus to the cell’s cytoplasm, where it guides the synthesis of proteins — the workhorses of biology. A key protein complex that helps to ferry messenger RNA from the nucleus has been poorly understood until now, however.

“Our research describes how this protein complex works at the molecular level,” says Ben Montpetit, a postdoctoral researcher in Karsten Weis’ lab at the University of California, Berkeley. Their research, a collaboration with biochemists Nathan Thomsen and James Berger, also of the University of California, Berkeley, is described in a paper published March 27 in an advance online edition of the journal Nature. Berger is also a faculty scientist in Berkeley Lab’s Physical Biosciences Division.

The scientists studied a protein called Dbp5 that resides at the nuclear pore complex of fungi, plant, and animal cells. In these organisms, it reshapes messenger RNA as part of a chain of events required to send it from the nucleus.

But that’s just the tip of the iceberg. Dbp5 is among a class of enzymes called DEAD-box ATPase that perform vital RNA-remodeling functions throughout nature, from humans and oak trees to fungi and single-celled bacteria. Understanding how it works in the cells of one species will illuminate how it works in distantly related species.

“DEAD-box proteins are conserved throughout life, so learning how it works in this case sheds light on its function everywhere in nature,” says Montpetit.

The scientists conducted their research at beamline 8.3.1 of the Advanced Light Source, a national user facility that generates intense x-rays to probe the fundamental properties of substances. They used the synchrotron to resolve the structure of Dbp5 from yeast cells at key steps of the enzyme’s job, such as when it’s activated by another protein called Gle1 and when it binds with RNA. The structures were obtained at resolutions of between one and four angstroms (one angstrom is the diameter of a hydrogen atom).

The result is a time-lapse series of the protein’s choreographed bid to remodel messenger RNA, with its twists and turns revealed at the highest resolution yet.

This video is not supported by your browser at this time.
The protein complex in action. In this simulation, Gle1 (yellow) binds Dbp5 (green and blue-grey), causing Dbp5 to release RNA (orange). The movie begins with Dbp5 bound to RNA and then transitions to the Gle1-Dbp5 state, the step that jettisons RNA. The simulation then plays in reverse to mimic RNA and ATP dependent closing of Dbp5 and release of Gle1 (Movie courtesy of Karsten Weis’ and James Berger’s labs)

Among the team’s most intriguing discoveries is the role of a molecule that is known to be involved in transport, but whose function was a mystery. They found that the molecule, called inositol hexakisphosphate, or IP6, tethers Gle1 to Dbp5. This stabilizes the two proteins long enough for Gle1 to kickstart Dbp5 into action.

“IP6 acts like a molecular glue,” says Montpetit. “This is one of the first examples of an endogenous small molecule functioning to bring larger protein molecules together. With this knowledge, scientists can now consider how IP6 may be used to regulate mRNA export under various conditions, such as in response to stress.”

Their research could also advance scientists’ understanding of a rare but devastating family of diseases called lethal congenital contracture syndrome. The mutation that causes this disease is mapped to the genes that produce both Gle1 and IP6. Now, with Gle1’s role in messenger transport further elucidated, the door opens for the development of therapies that target its function.

Explore further: Top Japan lab dismisses ground-breaking stem cell study

More information: The research is described in a Nature article titled, “A conserved mechanism of DEAD-box ATPase activation by nucleoporins and IP6 in mRNA export.” It was published online March 27, 2011.

Related Stories

Revealing a missing link

Nov 12, 2010

When it comes to genes, it’s definitely possible to have too much of a good thing. Accordingly, mammalian females have a mechanism that randomly inactivates one of the two X sex chromosomes within each ...

Recommended for you

Top Japan lab dismisses ground-breaking stem cell study

Dec 26, 2014

Japan's top research institute on Friday hammered the final nail in the coffin of what was once billed as a ground-breaking stem cell study, dismissing it as flawed and saying the work could have been fabricated.

Research sheds light on what causes cells to divide

Dec 24, 2014

When a rapidly-growing cell divides into two smaller cells, what triggers the split? Is it the size the growing cell eventually reaches? Or is the real trigger the time period over which the cell keeps growing ...

Locking mechanism found for 'scissors' that cut DNA

Dec 24, 2014

Researchers at Johns Hopkins have discovered what keeps an enzyme from becoming overzealous in its clipping of DNA. Since controlled clipping is required for the production of specialized immune system proteins, ...

Scrapie could breach the species barrier

Dec 24, 2014

INRA scientists have shown for the first time that the pathogens responsible for scrapie in small ruminants (prions) have the potential to convert the human prion protein from a healthy state to a pathological ...

Extracting bioactive compounds from marine microalgae

Dec 24, 2014

Microalgae can produce high value health compounds like omega-3s , traditionally sourced from fish. With declining fish stocks, an alternative source is imperative. Published in the Pertanika Journal of Tr ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.